Rapid increase in serotype 4 invasive pneumococcal disease among vulnerable young male adults in Belgium (2020-2024)
This study identifies a specific population of vulnerable adults at risk for serotype 4 IPD, emphasizing the need for a specific prevention strategy. Vaccination of this risk group with a pneumococcal vaccine targeting serotype 4 is needed to reduce the increasing burden of invasive disease caused by this vaccine serotype.
Authors
- Stefanie Desmet (ORCID: https://orcid.org/0000-0002-4338-1929)
- D Gilles
- David Nicolás
- Hermes Tóros Xavier (ORCID: https://orcid.org/0000-0002-0118-2518)
- P Henry
- Lize Cuypers (ORCID: https://orcid.org/0000-0002-9433-8752)
- Katrien Lagrou (ORCID: https://orcid.org/0000-0001-8668-1350)
- Alison Thomas (ORCID: https://orcid.org/0000-0002-1067-3909)
- Philippe Clevenbergh
- S J
- Naesens Reinout
- Buttafuoco Fabrizio
- Brassinne Laetitia
- Herrera Avila Juan Paulo
- Herens Sophie
- Hites Maya
- Layeux Brice
Institutions
- Université Libre de Bruxelles (BE)
- Rega Institute for Medical Research (BE)
- Centre Hospitalier Chrétien (BE)
- Centre Hospitalier Universitaire Brugmann (BE)
- Centre Hospitalier Interrégional Edith Cavell (BE)
- Hôpitaux Iris Sud (BE)
- Cliniques du Sud Luxembourg (BE)
- Ziekenhuisnetwerk Antwerpen Stuivenberg (BE)
- Grand Charleroi Hospital (BE)
- Centre hospitalier régional de la Citadelle (BE)
- KU Leuven (BE)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2025-11-16
- DOI
- https://doi.org/10.1016/j.ijid.2025.108216
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Fonds De La Recherche Scientifique - FNRS
- Institut National d'assurance Maladie-Invalidité